Transcarent has raised $58m from Bayer and Merck, while Nvidia has bought DeepMap, one of its portfolio companies also backed by Bosch.
Funding
US-based consumer-focused healthcare platform operator Transcarent has raised $58m in a series B round featuring Leaps by Bayer and Merck Global Health Innovation Fund, respective vehicles for pharmaceutical group Bayer and Merck, and co-led by 7wire Ventures and General Catalyst. The round also attracted Kleiner Perkins, GreatPoint Ventures, Threshold Ventures, Alta Partners and Jove Equity Partners. Transcarent has now raised $98m altogether, it said, identifying Alta and Jove as returning backers.
Heartseed, a Japan-based myocardial regenerative medicine developer…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
